Table. Characteristics of 112 Public Speakers at AADPAC Meetings, September 2009 to April 2017.
| Characteristic | No. (%) |
|---|---|
| Speaker reported experiencing chronic pain | 20 (17.9) |
| Speaker relationship with sponsor or drug under review | |
| Speaker has received drug under review | 11 (9.8) |
| Speaker was an investigator on trial of drug under review | 1 (0.9) |
| Speaker reported an organizational affiliation | 80 (71.4) |
| Speaker disclosed a COI | 22 (19.6) |
| Reimbursement for travel or other meeting expenses | 17 (15.2) |
| Financial association through an organization | 5 (4.5) |
| Investigator on drug trial | 1 (0.9) |
| Speaker had an undisclosed financial association through an organization | 21 (18.8) |
| Prior to the meeting in question | 6 (5.4) |
| Of indeterminate date | 15 (13.4) |
| Speaker position on drug approval | |
| Support | 76 (67.9) |
| Oppose | 28 (25.0) |
| Neutral | 8 (7.1) |
Abbreviations: AADPAC, Anesthetic and Analgesic Drug Products Advisory Committee; COI, conflict of interest.